SFG
IHE icon

StrategIQ Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

StrategIQ Financial Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$238K Hold
3,855
– – 0.03% 285
2023
Q3 		$227K Hold
3,855
– – 0.03% 281
2023
Q2 		$230K Hold
3,855
– – 0.03% 286
2023
Q1 		$225K Hold
3,855
– – 0.03% 268
2022
Q4 		$239K Hold
3,855
– – 0.03% 256
2022
Q3 		$218K Hold
3,855
– – 0.03% 257
2022
Q2 		$246K Hold
3,855
– – 0.03% 255
2022
Q1 		$250K Hold
3,855
– – 0.03% 269
2021
Q4 		$257K Buy
+3,855
New +$245K 0.03% 264

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return